Table 9.
Plasma ceramide | No lipid therapy* (n=60) | Lipid‐lowering therapy* (n=60) | P value |
---|---|---|---|
18:0, μmol/L | 0.08 (0.07; 0.12) | 0.10 (0.07; 0.13) | 0.096 |
16:0, μmol/L | 0.29 (0.26; 0.35) | 0.28 (0.24; 0.31) | 0.305 |
24:1, μmol/L | 0.78 (0.69; 0.93) | 0.77 (0.63; 0.96) | 0.813 |
24:0, μmol/L | 3.05 (2.73; 3.87) | 2.93 (2.68; 3.43) | 0.950 |
16:0/24:0 | 0.09 (0.08; 0.11) | 0.09 (0.08; 0.11) | 0.337 |
18:0/24:0 | 0.03 (0.02; 0.04) | 0.03 (0.03; 0.04) | 0.037 |
24:1/24:0 | 0.25 (0.22; 0.31) | 0.26 (0.21; 0.32) | 0.620 |
Data are presented as median (interquartile range).